OTCMKTS:TBUFF Tribute Pharmaceuticals Canada - TBUFF Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Tribute Pharmaceuticals Canada Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume50,100 shsAverage Volume71,826 shsMarket Capitalization$105.76 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartInsider TradesHeadlines About Tribute Pharmaceuticals Canada (OTCMKTS:TBUFF) StockTribute Pharmaceuticals Canada Inc., formerly Stellar Pharmaceuticals Inc., is a Canadian pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada. The Company targets several therapeutic areas in Canada but has a particular interest in products for the treatment of pain, urology, dermatology and endocrinology/cardiology. It also sells Uracyst and NeoVisc internationally through a number of strategic partnerships. On December 1, 2011, it acquired 100% of Tribute Pharmaceuticals Canada Ltd. and Tribute Pharma Canada Inc. As of December 31, 2011, its portfolio of assets includes nine products: NeoVisc, NeoVisc Single Dose, Uracyst, BladderChek, Bezalip SR, Soriatane, Cambia, Daraprim, and MycoVa. It has licensed BladderChek for the Canadian market from Inverness Medical Innovations North America, Inc. It eveloped Uracyst, a sterile 2 % sodium chondroitin sulfate solution available in a 20 milliliter vial.Read More Receive TBUFF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tribute Pharmaceuticals Canada and its competitors with MarketBeat's FREE daily newsletter. Email Address TBUFF Stock News HeadlinesSeptember 18, 2022 | investing.comTribute Pharmaceuticals Canada Inc (TRX)September 25, 2020 | reuters.comCanada police say six ricin-laced letters sent to U.S., including White HouseFebruary 5, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.September 25, 2020 | theglobeandmail.comPolitics Briefing: Youth-led climate protests hit cities around the worldSeptember 24, 2020 | msn.comKnoxville Biz Ticker: TDK breaks ground on new vintage developmentSeptember 23, 2020 | businesswire.comCerebras Systems Expands Global Footprint with New Offices in Tokyo, Japan, and Toronto, CanadaSeptember 10, 2020 | msn.comLupita Nyong'o wrote a heartbreaking tribute to Chadwick BosemanAugust 7, 2020 | finanznachrichten.deThe Royal Canadian Mint Recognizes the 150th Anniversary of the Northwest Territories in its Newest Suite of Collector CoinsFebruary 5, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.August 6, 2020 | msn.comNFL player gets second-most famous Halo tattooJuly 27, 2020 | www.msn.comTribute planned for NHS and key workers as Premier League, EFL, cricket and rugby union say thank youJuly 16, 2020 | www.msn.comRussia is hacking virus vaccine trials, US, UK, Canada sayJuly 16, 2020 | www.msn.comUK, US, Canada accuse Russia of hacking virus vaccine trialsJune 16, 2020 | www.msn.comSushant Singh Rajput's suicide: CM Pinarayi Vijayan recalls actor’s support during Kerala floodsJune 7, 2020 | www.msn.comTwitter disables Donald Trump campaign’s George Floyd video tributeMay 2, 2020 | www.foxnews.comJoe Biden denies sexual assault allegation, but personal records remain inaccessibleApril 21, 2020 | finance.yahoo.comEuropean Respiratory Devices Market 2020 by Product, End-user and Region - ResearchAndMarkets.comApril 19, 2020 | www.foxnews.comNancy Pelosi on negotiations over small business relief program, criticism of Trump's plan to reopen nationApril 2, 2020 | seekingalpha.comThe End Of MoneyFebruary 12, 2020 | www.finanznachrichten.deInnoCan Provides Update and Summary About Its Corporate Progress as Its First Products Prepare to Enter the Commercial MarketplaceSee More Headlines Receive TBUFF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tribute Pharmaceuticals Canada and its competitors with MarketBeat's FREE daily newsletter. Email Address TBUFF Company Calendar Last Earnings3/31/2014Today2/05/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry N/A Sub-IndustryN/A SectorN/A Current SymbolOTCMKTS:TBUFF CUSIPN/A CIKN/A Webwww.tributepharma.ca Phone+1-905-8761118FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares113,720,000Free FloatN/AMarket Cap$105.76 million OptionableNot Optionable BetaN/A Key ExecutivesArnold Tenney (Age 70)Chairman of the Board Robert Harris (Age 57)President, Chief Executive Officer, Director Scott Langille (Age 56)Chief Financial Officer, Director Janice M. Clarke (Age 52)Vice President - Finance and Administration Steven H. Goldman (Age 57)Independent Director John M. Gregory (Age 60)Independent Director John J. Kime (Age 70)Independent Director Francis Martin Thrasher (Age 61)Independent Director More Executives TBUFF Stock - Frequently Asked Questions How were Tribute Pharmaceuticals Canada's earnings last quarter? Tribute Pharmaceuticals Canada Inc. (OTCMKTS:TBUFF) announced its earnings results on Monday, March, 31st. The company reported ($0.01) earnings per share for the quarter, topping analysts' consensus estimates of ($0.02) by $0.01. The company earned $2.90 million during the quarter. What is Tribute Pharmaceuticals Canada's stock symbol? Tribute Pharmaceuticals Canada trades on the OTCMKTS under the ticker symbol "TBUFF." How do I buy shares of Tribute Pharmaceuticals Canada? Shares of TBUFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. How much money does Tribute Pharmaceuticals Canada make? Tribute Pharmaceuticals Canada (OTCMKTS:TBUFF) has a market capitalization of $0.00. How can I contact Tribute Pharmaceuticals Canada? Tribute Pharmaceuticals Canada's mailing address is 151 Steeles Ave. E., MILTON, ON L9T 1Y1, Canada. The official website for the company is www.tributepharma.ca. The company can be reached via phone at +1-905-8761118. This page (OTCMKTS:TBUFF) was last updated on 2/5/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.